CORONA acquires Myoril brand from Sanofi Healthcare
The acquisition of the Myoril brand for the Indian market is effective from June 28, 2023
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sanofi
Sanofi receives SEC recommendation to bring new therapies of Pompe, ASMD to India
The company hopes to launch these therapies in India by end of 2023 or beginning of next year, subject to completion of all…
J&J appoints Dr John Reed as EVP, Pharma, R&D
Dr Reed will join J&J on April 3, 2023, assuming responsibility for the company’s portfolio from Dr William Hait, who has…
USFDA accepts AstraZeneca’s BLA for nirsevimab to prevent RSV lower respiratory tract disease
Nirsevimab is being developed and commercialised by AstraZeneca in collaboration with Sanofi, and is the first single-dose…
Sanofi sees decision on Zantac dispute with Boehringer in Q1
The two companies are in arbitration to decide what Sanofi's obligations might be, given Sanofi acquired the marketing rights to…
Pharma industry to hike prices on over 350 drugs in US
The increases are expected to come as the pharma industry prepares for the Biden Administration's Inflation Reduction Act (IRA),…
French health authority advises against use of Valneva’s COVID-19 vaccine
The snub caused Valneva's shares to fall, with Valneva down by around one per cent during the late morning trading session in…
GSK, Pfizer and Sanofi escape US federal litigation over Zantac
While the companies, which have all marketed the drug at different times, still face tens of thousands of similar lawsuits in…
Provention Bio diabetes drug to cost $13,850/vial
The US Food and Drug Administration (FDA) approved use of the drug, to be sold under brand name Tzield, for delaying the onset of…
Sanofi and AstraZeneca win EU approval for prevention of infant RSV
The long-acting therapy, also known as nirsevimab, was given the European Union (EU) marketing authorisation for the prevention of…